MLchartDataset catalogue

Treg inhibitor GIM-531

Term · Oncology and biomedicine · MLC-T-ONC-017309

An orally bioavailable small molecule inhibitor of regulatory T-cells (Tregs), with potential immunomodulatory and antineoplastic activities. Upon oral administration, Treg inhibitor GIM-531 inhibits the activity of immune suppressive Tregs through an as of yet unknown mechanism of action. This may restore antitumor immune responses.

Table 1. Record
IdentifierMLC-T-ONC-017309
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-017309",
  "term": "Treg inhibitor GIM-531",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable small molecule inhibitor of regulatory T-cells (Tregs), with potential immunomodulatory and antineoplastic activities. Upon oral administration, Treg inhibitor GIM-531 inhibits the activity of immune suppressive Tregs through an as of yet unknown mechanism of action. This may restore antitumor immune responses.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/treg-inhibitor-gim-531/"
}

Record 16,685 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.